Latest China Market News

Appen Limited reported robust 2024 results with a 16% revenue increase excluding Google and a return to profitability, driven by generative AI projects and China market expansion. The company outlines a confident 2025 strategy focused on AI data quality, operational efficiency, and sustained growth.

Wide Open Agriculture secures $2.6 million via placement and plans a $500,000 Share Purchase Plan to fast-track its expansion into China and boost global sales of its lupin protein products.

Australian Dairy Nutritionals Limited reported a record $736k revenue from nutritional powders in Q3 FY25, driven by its new Future brand launch in China and expanding sales in Vietnam. The company’s strategic partnerships and premium product positioning signal a pivotal shift in its growth trajectory.

Wide Open Agriculture has inked an exclusive 18-month distribution agreement with Univar Solutions China to market its lupin protein products, marking a strategic push into the lucrative Chinese plant-based protein sector.

Industrial Minerals Ltd has reported promising progress in its high purity quartz beneficiation and ore-sorting trials at the Pippingarra Pegmatite Project, with growing interest from Asian markets and potential new co-products enhancing project economics.

Syrah Resources halts production at its Balama graphite mine amid ongoing protests while advancing its US-based Vidalia anode material facility, securing a significant $165 million US tax credit and forging key offtake deals.

The a2 Milk Company posted robust first-half FY25 results, lifting revenue by 10.1% and net profit by 7.6%, while introducing a dividend policy for the first time. Strong English label IMF sales and liquid milk growth underpin an upgraded full-year outlook.

The a2 Milk Company delivered solid first-half FY25 results with revenue up 10.1% and net profit rising 7.6%, driven by strong growth in China and the USA despite supply constraints and ANZ challenges. The company also declared its first-ever interim dividend and upgraded its full-year outlook.

The a2 Milk Company has reported robust first-half FY25 results, boosting full-year guidance and declaring its inaugural dividend, underscoring confidence in its growth trajectory.

Jindalee Lithium’s latest quarterly report confirms a 63-year life for its McDermitt Lithium Project, underpinned by robust financial metrics and a maiden ore reserve that taps just a fraction of its vast resource.

AdAlta Limited has bolstered its leadership team and progressed its 'East to West' cellular therapy strategy alongside its lead drug candidate AD-214, despite a tightening cash position. The company’s recent non-binding term sheet and new clinical data signal promising momentum in its biotech pipeline.

Fluence Corporation Limited delivered a standout Q4 2024 with $21.2 million revenue and $1 million EBITDA, driven by a strategic shift to higher-margin Smart Product Solutions. The company’s robust $88 million backlog and $50 million in new orders set the stage for ambitious growth in 2025.